BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36973247)

  • 1. Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England.
    Nafilyan V; Bermingham CR; Ward IL; Morgan J; Zaccardi F; Khunti K; Stanborough J; Banerjee A; Doidge JC
    Nat Commun; 2023 Mar; 14(1):1541. PubMed ID: 36973247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
    Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
    BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis.
    Gurdasani D; Bhatt S; Costello A; Denaxas S; Flaxman S; Greenhalgh T; Griffin S; Hyde Z; Katzourakis A; McKee M; Michie S; Ratmann O; Reicher S; Scally G; Tomlinson C; Yates C; Ziauddeen H; Pagel C
    J R Soc Med; 2021 Nov; 114(11):513-524. PubMed ID: 34723680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers' unvaccinated household members.
    Salo J; Hägg M; Kortelainen M; Leino T; Saxell T; Siikanen M; Sääksvuori L
    Nat Commun; 2022 Mar; 13(1):1162. PubMed ID: 35246536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers.
    Luk A; Clarke B; Dahdah N; Ducharme A; Krahn A; McCrindle B; Mizzi T; Naus M; Udell JA; Virani S; Zieroth S; McDonald M
    Can J Cardiol; 2021 Oct; 37(10):1629-1634. PubMed ID: 34375696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study.
    Tzur Bitan D; Kridin K; Cohen AD; Weinstein O
    Lancet Psychiatry; 2021 Oct; 8(10):901-908. PubMed ID: 34364406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
    Corchado-Garcia J; Zemmour D; Hughes T; Bandi H; Cristea-Platon T; Lenehan P; Pawlowski C; Bade S; O'Horo JC; Gores GJ; Williams AW; Badley AD; Halamka J; Virk A; Swift MD; Wagner T; Soundararajan V
    JAMA Netw Open; 2021 Nov; 4(11):e2132540. PubMed ID: 34726743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination.
    Mades A; Chellamathu P; Kojima N; Lopez L; MacMullan MA; Denny N; Angel AN; Santacruz M; Casian JG; Brobeck M; Nirema N; Klausner JD; Turner F; Slepnev VI; Ibrayeva A
    Sci Rep; 2021 Dec; 11(1):24448. PubMed ID: 34961780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
    Hippisley-Cox J; Coupland CA; Mehta N; Keogh RH; Diaz-Ordaz K; Khunti K; Lyons RA; Kee F; Sheikh A; Rahman S; Valabhji J; Harrison EM; Sellen P; Haq N; Semple MG; Johnson PWM; Hayward A; Nguyen-Van-Tam JS
    BMJ; 2021 Sep; 374():n2244. PubMed ID: 34535466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    Efe C; Taşçılar K; Gerussi A; Bolis F; Lammert C; Ebik B; Stättermayer AF; Cengiz M; Gökçe DT; Cristoferi L; Peralta M; Massoumi H; Montes P; Cerda E; Rigamonti C; Yapalı S; Adali G; Çalışkan AR; Balaban Y; Eren F; Eşkazan T; Barutçu S; Lytvyak E; Zazueta GM; Kayhan MA; Heurgue-Berlot A; De Martin E; Yavuz A; Bıyık M; Narro GC; Duman S; Hernandez N; Gatselis NK; Aguirre J; Idilman R; Silva M; Mendizabal M; Atay K; Güzelbulut F; Dhanasekaran R; Montano-Loza AJ; Dalekos GN; Ridruejo E; Invernizzi P; Wahlin S
    J Autoimmun; 2022 Oct; 132():102906. PubMed ID: 36088883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.
    Naleway AL; Groom HC; Crawford PM; Salas SB; Henninger ML; Donald JL; Smith N; Thompson MG; Blanton LH; Bozio CH; Azziz-Baumgartner E
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(46):1608-1612. PubMed ID: 34793417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.